Stocks Health care MIST
NASDAQ · Health careMilestone Pharmaceuticals Inc. (MIST)
It posted a net loss of $84M. In fiscal 2025 capital spending exceeded operating cash flow by $49.3M. At June 30, 2026 it held $169.7M in cash against $59.2M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 12, 2026.
What Milestone Pharmaceuticals Inc. does
Milestone Pharmaceuticals Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker MIST.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$63.1M | -$0.75 | -$49.3M |
| 2024 | n/a | -$41.5M | -$0.67 | -$28.9M |
| 2023 | n/a | -$59.7M | -$1.39 | -$46.5M |
| 2022 | n/a | -$58.4M | -$1.38 | -$52.7M |
| 2021 | n/a | -$42.9M | -$1.02 | n/a |
| 2020 | n/a | -$50M | -$1.70 | n/a |
Latest SEC filings
What Milestone Pharmaceuticals Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 3, 2026Other event 8-K
- August 12, 2026
- August 12, 2026Quarterly report 10-Q · period to June 30, 2026
- August 7, 2026Passive stake (5% or more) SCHEDULE 13G
- June 15, 2026
- May 15, 2026Passive stake changed SCHEDULE 13G/A
- May 13, 2026
- May 13, 2026Passive stake changed SCHEDULE 13G/A
- May 13, 2026
- May 13, 2026Quarterly report 10-Q · period to March 31, 2026
Questions about MIST
What does Milestone Pharmaceuticals Inc. do?
Milestone Pharmaceuticals Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker MIST.
Is Milestone Pharmaceuticals Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $84M.
When did Milestone Pharmaceuticals Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 12, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the other event from September 3, 2026.
Similar companies
Follow MIST
Get an email when Milestone Pharmaceuticals Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow MIST: get an email when it filesWhere the numbers come from
Financial figures are the values Milestone Pharmaceuticals Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.